Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:326-333

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collard, C. D.
Right arrow Articles by Stahl, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collard, C. D.
Right arrow Articles by Stahl, G. L.

(Circulation. 1997;96:326-333.)
© 1997 American Heart Association, Inc.


Articles

Reoxygenation of Hypoxic Human Umbilical Vein Endothelial Cells Activates the Classic Complement Pathway

Charles D. Collard, MD; Antti Väkevä, MD, PhD; Cüneyt Büküsoglu, PhD; Gregor Zünd, MD; C. John Sperati, BS; Sean P. Colgan, PhD; ; Gregory L. Stahl, PhD

From the Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Gregory L. Stahl, PhD, Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115. E-mail gstahl{at}zeus.bwh.harvard.edu

Background Ischemia-reperfusion injury leads to the activation and endothelial deposition of complement. We investigated whether exposure of human umbilical vein endothelial cells (HUVECs) to hypoxia and/or reoxygenation activates complement and decreases HUVEC-surface expression of the C3 regulatory proteins CD46 and CD55.

Methods and Results HUVECs were subjected to 0, 12, or 24 hours of hypoxia (O2=1%) and then reoxygenated for 3 hours (O2=21%) in the presence of 30% human serum. C3 deposition and HUVEC-surface expression of CD46 and CD55 were evaluated by ELISA and flow cytometry. C3 deposition on HUVECs subjected to 12 or 24 hours of hypoxia followed by 3 hours of reoxygenation was significantly greater than normoxic HUVECs. Inhibition of the classic but not the alternative complement pathway during reoxygenation attenuated C3 deposition. Western blot analysis of HUVEC lysates under reducing conditions demonstrated significantly increased iC3b deposition in hypoxic/reoxygenated HUVECs compared with normoxic HUVECs. FACS analysis confirmed iC3b deposition. HUVEC-surface expression of CD46 and CD55 increased after hypoxia and/or reoxygenation.

Conclusions We conclude that (1) hypoxia and reoxygenation of HUVECs significantly increases iC3b deposition on HUVECs, (2) C3 deposition after hypoxia and reoxygenation is largely mediated by the classic complement pathway, and (3) HUVEC-surface expression of CD46 and CD55 increases after hypoxia and reoxygenation. These data demonstrate that hypoxia and reoxygenation of human endothelial cells activates the classic complement pathway despite an increase in complement C3 regulatory proteins.


Key Words: endothelium • hypoxia • ischemia • reperfusion




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. R. La Bonte, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh
Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1282 - H1290.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Zhang, K. Takahashi, E. M. Alicot, T. Vorup-Jensen, B. Kessler, S. Thiel, J. C. Jensenius, R. A. B. Ezekowitz, F. D. Moore, and M. C. Carroll
Activation of the Lectin Pathway by Natural IgM in a Model of Ischemia/Reperfusion Injury
J. Immunol., October 1, 2006; 177(7): 4727 - 4734.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. A. Louis, K. E. Hamilton, T. Kong, and S. P. Colgan
HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils
FASEB J, June 1, 2005; 19(8): 950 - 959.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. D. Collard, M. C. Montalto, W. R. Reenstra, J. A. Buras, and G. L. Stahl
Endothelial Oxidative Stress Activates the Lectin Complement Pathway : Role of Cytokeratin 1
Am. J. Pathol., September 1, 2001; 159(3): 1045 - 1054.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Montalto, C. D. Collard, J. A. Buras, W. R. Reenstra, R. McClaine, D. R. Gies, R. P. Rother, and G. L. Stahl
A Keratin Peptide Inhibits Mannose-Binding Lectin
J. Immunol., March 15, 2001; 166(6): 4148 - 4153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. J. Tanhehco, K. Yasojima, P. L. McGeer, R. A. Washington, and B. R. Lucchesi
Free radicals upregulate complement expression in rabbit isolated heart
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H195 - H201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. D. Collard, A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Meri, and G. L. Stahl
Complement Activation after Oxidative Stress : Role of the Lectin Complement Pathway
Am. J. Pathol., May 1, 2000; 156(5): 1549 - 1556.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Lindner, M. P. Coggins, S. Kaul, A. L. Klibanov, G. H. Brandenburger, and K. Ley
Microbubble Persistence in the Microcirculation During Ischemia/Reperfusion and Inflammation Is Caused by Integrin- and Complement-Mediated Adherence to Activated Leukocytes
Circulation, February 15, 2000; 101(6): 668 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. J. Tanhehco, K. Yasojima, P. L. McGeer, and B. R. Lucchesi
Acute Cocaine Exposure Up-Regulates Complement Expression in Rabbit Heart
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 201 - 208.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl
Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2623 - 2629.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Z. Prohaszka, J. Duba, G. Lakos, E. Kiss, L. Varga, L. Janoskuti, A. Csaszar, I. Karadi, K. Nagy, M. Singh, et al.
Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability
Int. Immunol., September 1, 1999; 11(9): 1363 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. D. Collard, C. Bukusoglu, A. Agah, S. P. Colgan, W. R. Reenstra, B. P. Morgan, and G. L. Stahl
Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells
Am J Physiol Cell Physiol, February 1, 1999; 276(2): C450 - C458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Park, M. Haas, P. N. Cunningham, L. Bao, J. J. Alexander, and R. J. Quigg
Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes
Am J Physiol Renal Physiol, February 1, 2002; 282(2): F352 - F357.
[Abstract] [Full Text] [PDF]